Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab, chemotherapy and hormone therapy for breast cancer (KEYNOTE-756)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at adding a drug called pembrolizumab to chemotherapy and hormone therapy for newly diagnosed breast cancer.

It is for people whose cancer is HER2 negative and oestrogen (ER) positive. This means the breast cancer cells:

  • don’t have receptors for

  • do have receptors for

Recruitment start: 5 February 2019

Recruitment end: 15 August 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Schmid

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 30 June 2024

CRUK internal database number: 16042

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.